TMCnet News

Research and Markets: Global Depression Drugs Market 2015-2019: Antidepressants are Losing Steam in the Face of Alternative Treatment
[June 24, 2015]

Research and Markets: Global Depression Drugs Market 2015-2019: Antidepressants are Losing Steam in the Face of Alternative Treatment


Research and Markets (http://www.researchandmarkets.com/research/rwn2t9/global_depression) has announced the addition of the "Global Depression Drugs Market 2015-2019" report to their offering.

The analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.

Key vendors

- Actavis

- Bristol-Myers Squibb

- Eli Lilly

- GlaxoSmithKline

- Pfizer

Other prominent vendors

- Abbott Laboratories

- Addex Therapeutics

- Alkermes

- AstraZeneca

- Aurobindo Pharma

- Avanir Pharmaceuticals

- Cerecor

- Chugai Pharmaceutical

- Dart NeuroScience

- Dr. Reddy's Laboratories

- Edgemont Pharmaceuticals

- E-Therapeutics

- Euthymics

- Evotec

- F. Hoffmann-La Roche

- Fare Kramer



- Gedeon Richter

- H. Lundbeck


- Intra-Cellular Therapies

- Janssen Pharmaceuticals

- Lupin

- Luye Pharma

- MSI (News - Alert) Methylation Sciences

- Naurex

- Neuralstem

- Novartis

- Opko Health

- Otsuka Pharmaceutical

- Pierre Fabre

- Shire

- SK Biopharmaceuticals

- Somerset Pharmaceuticals

- Sun Pharmaceutical

- Sunovion Pharmaceuticals

- Suven

- Takeda Pharmaceutical

- Teva Pharmaceutical

- Torrent Pharmaceuticals

- Valeant Pharmaceuticals

Commenting on the report, an analyst from the team said: Growing public awareness about depression is expected to increase the acceptability of various drugs. The Anxiety and Depression Association of America, Mental Health America, Depression and Bipolar Support Alliance, Suicide Awareness, Voices of Education, and Freedom from Fear are non-profit organizations involved in spreading awareness of depression and its implications.

According to the report, WHO has described depression as one of the most disabling illnesses worldwide. In 2012, it was estimated that more than 18 million people suffered from depression in the US, affecting about 25% of women and 10% of men. According to the CDC, about one in every 10 individuals in the US suffers from depression.

For more information visit http://www.researchandmarkets.com/research/rwn2t9/global_depression

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To TMCnet.com's Homepage ]